These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 3145088)
21. Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs. Pretolani M; Lefort J; Venco C; Perrisoud D; Vargaftig BB Eur J Pharmacol; 1992 Jun; 216(2):141-7. PubMed ID: 1397002 [TBL] [Abstract][Full Text] [Related]
22. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. Malo PE; Wasserman MA; Pfeiffer DF Prostaglandins; 1987 Feb; 33(2):209-25. PubMed ID: 3588971 [TBL] [Abstract][Full Text] [Related]
23. Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro. Tennant CM; Seale JP; Temple DM J Pharm Pharmacol; 1987 Apr; 39(4):309-11. PubMed ID: 2438401 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of antigen-induced contraction of guinea pig trachea by ICI 198,615. Redkar-Brown DG; Aharony D Eur J Pharmacol; 1989 Jun; 165(1):113-21. PubMed ID: 2767127 [TBL] [Abstract][Full Text] [Related]
25. Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. Anderson GP; Fennessy MR Agents Actions Suppl; 1988; 23():195-200. PubMed ID: 3140616 [TBL] [Abstract][Full Text] [Related]
26. Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action. Nijkamp FP; Folkerts G; Beetens JR; De Clerck F Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):111-8. PubMed ID: 2571942 [TBL] [Abstract][Full Text] [Related]
27. Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips. Touvay C; Vilain B; Sirois P; Soufir M; Braquet P J Pharm Pharmacol; 1987 Jun; 39(6):454-8. PubMed ID: 2886603 [TBL] [Abstract][Full Text] [Related]
28. Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites. Del Monte M; Subissi A Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):417-21. PubMed ID: 3149718 [TBL] [Abstract][Full Text] [Related]
29. Pharmacological modulation of platelet activating factor (PAF)-induced bronchoconstriction and hypertension in anaesthetized guinea-pigs. Iwama T; Shikada K; Tanaka S J Pharm Pharmacol; 1988 Aug; 40(8):544-7. PubMed ID: 2907007 [TBL] [Abstract][Full Text] [Related]
30. The effect of platelet-activating factor on histamine and muscarinic receptor function in guinea pig airways. Robertson DN; Coyle AJ; Rhoden KJ; Grandordy B; Page CP; Barnes PJ Am Rev Respir Dis; 1988 Jun; 137(6):1317-22. PubMed ID: 2849329 [TBL] [Abstract][Full Text] [Related]
31. Effect of long-term infusion of platelet-activating factor on pulmonary responsiveness and morphology in the guinea-pig. Touvay C; Pfister A; Vilain B; Carré C; Page CP; Lellouch-Tubiana A; Pignol B; Mencia-Huerta JM; Braquet P Pulm Pharmacol; 1991; 4(1):43-51. PubMed ID: 1804494 [TBL] [Abstract][Full Text] [Related]
32. Aerosolized and intravenously administered leukotrienes: effects on the bronchoconstrictor potency of histamine in the guinea-pig. Fennessy MR; Stewart AG; Thompson DC Br J Pharmacol; 1986 Apr; 87(4):741-9. PubMed ID: 3708207 [TBL] [Abstract][Full Text] [Related]
33. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. Pretolani M; Lefort J; Vargaftig BB Am Rev Respir Dis; 1988 Dec; 138(6):1572-8. PubMed ID: 3202509 [TBL] [Abstract][Full Text] [Related]
34. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin. Pedersen KE; Rigby PJ; Goldie RG Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758 [TBL] [Abstract][Full Text] [Related]
35. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs. Yanagihara Y; Kasai H; Matsui S; Ninomiya K Jpn J Pharmacol; 1989 Sep; 51(1):83-92. PubMed ID: 2478743 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of action of platelet-activating factor on guinea-pig lung parenchyma strips. Jancar S; Thériault P; Provençal B; Cloutier S; Sirois P Can J Physiol Pharmacol; 1988 Sep; 66(9):1187-91. PubMed ID: 3146431 [TBL] [Abstract][Full Text] [Related]
37. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [TBL] [Abstract][Full Text] [Related]
38. Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4. Conroy DM; Samhoun MN; Piper PJ Br J Pharmacol; 1991 Dec; 104(4):1012-8. PubMed ID: 1725762 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists. Darius H; Smith JB; Lefer AM Int Arch Allergy Appl Immunol; 1986; 80(4):369-75. PubMed ID: 3015804 [TBL] [Abstract][Full Text] [Related]
40. Antagonism by ETYA of the effects of leukotrienes on ileum and lung parenchymal strips independent of effects on arachidonic acid metabolism. Hageman WE; Rose MP; Persico FJ Prostaglandins; 1986 Oct; 32(4):563-78. PubMed ID: 3099334 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]